Showing results (1-10 of 178) with videos related to

Sort By:
Pageof 18
Expert Review of Cardiovascular Therapy|April 9, 2025
What is the impact of dynamic score reassessment for stroke and bleeding risk outcome prediction in atrial fibrillation patients?Eva Soler-Espejo, Francisco Marín, Vanessa Roldán, et al.
The American Journal of Clinical Nutrition|January 1, 2026
Prognostic value of adiposity indices in anticoagulated patients with atrial fibrillation: The prospective Murcia AF Project III cohortEva Soler-Espejo, Yang Chen, Vanessa Roldán, et al.
Revista Espanola De Cardiologia (English Ed.)|March 9, 2024
Dynamic assessment of CHA2DS2-VASc and HAS-BLED scores for predicting ischemic stroke and major bleeding in atrial fibrillation patientsMaría José Serna, José Miguel Rivera-Caravaca, Raquel López-Gálvez, et al.
Journal of the American Heart Association|March 10, 2026
Atherogenic Index of Plasma and Residual Risk in Anticoagulated Patients With Atrial Fibrillation: The Prospective Murcia Atrial Fibrillation Project III CohortEva Soler-Espejo, Yang Chen, José M Rivera-Caravaca, et al.
Expert Review of Neurotherapeutics|July 23, 2024
Advances in the medical treatment and diagnosis of intracranial hemorrhage associated with oral anticoagulationClaudio Piqueras-Sanchez, María Asunción Esteve-Pastor, Jorge Moreno-Fernandez, et al.
Journal of Thrombosis and Haemostasis : JTH|August 22, 2025
A comparative analysis of HAS-BLED, ORBIT, DOAC and AF-BLEED bleeding risk scores in anticoagulated patients with atrial fibrillation: A report from the prospective Murcia AF Project III (MAFP-III) cohortEva Soler-Espejo, María Pilar Ramos-Bratos, José Miguel Rivera-Caravaca, et al.
European Journal of Preventive Cardiology|May 14, 2025
Association between baseline adherence to a healthy lifestyle with ischemic and major cardiovascular events in patients with atrial fibrillationEva Soler-Espejo, María Pilar Ramos-Bratos, Eduardo González-Lozano, et al.
Thrombosis and Haemostasis|February 5, 2026
Beyond factor levels: guiding surgical haemostasis in inherited factor VII deficiencyEva Soler-Espejo, Vanessa Roldan, Francisco Marín
Internal and Emergency Medicine|July 4, 2024
Patients with atrial fibrillation and common exclusion criteria from clinical trials are at high risk of clinical events: the Murcia AF Project II (MAFP-II) cohort studyEva Soler-Espejo, José Miguel Rivera-Caravaca, José Daniel Bru-Cánovas, et al.
Cardiovascular Diabetology|July 10, 2025
Remnant-to-LDL cholesterol discordance as a predictor of thromboembolic events in anticoagulated patients with atrial fibrillation: a report from the prospective Murcia AF project III (MAFP-III) cohort studyEva Soler-Espejo, Yang Chen, José Miguel Rivera-Caravaca, et al.
Pageof 18